story of the week
Subgroup Analyses of the Outcomes of Sacituzumab Govitecan Therapy for Metastatic TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
NPJ Breast Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer
NPJ Breast Cancer 2024 Apr 25;10(1)33, SA Hurvitz, A Bardia, K Punie, K Kalinsky, LA Carey, HS Rugo, V Diéras, S Phan, R Delaney, Y Zhu, SM TolaneyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.